APA (7th ed.) Citation

Pandith, A. A., Qasim, I., Zahoor, W., Shah, P., Bhat, A. R., Sanadhya, D., . . . Naikoo, N. A. (2018). Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide). Nature Portfolio.

Chicago Style (17th ed.) Citation

Pandith, Arshad A., Iqbal Qasim, Wani Zahoor, Parveen Shah, Abdul R. Bhat, Dheera Sanadhya, Zafar A. Shah, and Niyaz A. Naikoo. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.

MLA (8th ed.) Citation

Pandith, Arshad A., et al. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.